Twelve US Health Systems Join Aidoc To Form Diagnostic AI Consortium
Twelve US health systems, including Advocate Health, Cedars-Sinai and Northwell Health, have joined Aidoc to develop diagnostic AI, with results expected in 2027.
Pharma
AI at work across drug discovery, clinical trials and life sciences.
Research: AIM Research reports on Pharma AI →Page 3
LCMC Health Partners With Qualified Health to Expand Enterprise AI Across Care
LCMC Health is partnering with Qualified Health to deploy generative AI across clinical, operational, and revenue-cycle workflows.
Hims & Hers Is Building AI into Its Consumer Healthcare Business
Hims & Hers is using AI to connect customers, clinicians, labs and support teams as it expands beyond its original telehealth model.
Kyndryl to Acquire Healthcare IT Leaders to Expand AI-Led Healthcare Modernization
Kyndryl plans to add Healthcare IT Leaders' healthcare application and consulting capabilities to its infrastructure and AI services.
Doximity Ramps AI Spending as Hospitals Shift Toward Enterprise Adoption
Doximity raised its fiscal 2027 outlook as 165 health systems adopted its AI tools, while higher AI spending weighs on near-term margins.
Evolent Bets on AI-Led Operations as It Raises 2026 Revenue Outlook
Evolent raised its 2026 revenue guidance after reporting 47% revenue growth in Q2, with executives pointing to an AI-led operating model and new oncology partnerships.
Hims & Hers Embedded AI Into Its Weight Loss Care Experience
"This new experience on the Hers app embeds intelligence at every step of the care experience."
Astrana Health Credits AI-Native Platform as Q2 Revenue Climbs 49%
Astrana Health raised its 2026 EBITDA outlook after reporting strong second-quarter growth driven by its AI-native healthcare platform.
AI Stayed in the Background During Lilly and Novartis' Earnings Calls
Eli Lilly and Novartis spent little time discussing quarterly earnings, focusing instead on R&D, acquisitions, and the next generation of medicines.
GenScript Partners With Tamarind Bio to Speed AI Drug Discovery Validation
GenScript and Tamarind Bio have partnered to connect AI-powered molecular design with wet-lab validation, aiming to help researchers evaluate drug candidates faster.
Leadership move
Syneos Health Appoints Rajneesh Patil to Lead AI and Innovation for Clinical Development
The appointment comes as the company expands its use of artificial intelligence across clinical research and drug development workflows.
GE HealthCare Brings AI to Breast Imaging and Portable Ultrasound
GE HealthCare introduced new AI-enabled ultrasound platforms for breast imaging and point-of-care care, expanding automation across screening, diagnosis, and clinical imaging.
Twist Bioscience Expects Triple-Digit AI Drug Discovery Growth Through FY27
Minimum triple-digit growth sets the company’s AI orders to surge from ~$25M in FY25 to at least $100M by FY27.
Providence Expands AI-Powered Genetic Screening to Detect Inherited Cancer Risks Earlier
Providence is using AI to identify cancer patients who may benefit from genetic testing, helping detect inherited cancer risks earlier and improve treatment decisions.
Labcorp Layers AI Across Consumer Health and Diagnostics as Growth Accelerates
Labcorp's Q2 results show AI is supporting consumer health, specialty diagnostics, and clinical research as the company raises its 2026 outlook.
WellSpan Health Expands Hippocratic AI Partnership to Cover Full Patient Journey
AI agent Ana already handles more than 160,000 patient calls per month across WellSpan's network, the company said.
GE HealthCare Says AI-Enabled Innovation Helped Drive Record Orders in Q2
GE HealthCare reported record orders growth in Q2 2026, driven by AI-enabled products and enterprise demand.
Mount Sinai Extends Epic Ambient AI Tool to Nurses After Cutting Physician Documentation Time
Mount Sinai Medical Center has expanded Epic's ambient AI documentation tool to inpatient nurses after physicians reduced charting time per encounter by nearly 30%.
AI-Driven Demand Fuels Thermo Fisher's Earnings Beat and Raised Outlook
AI-fueled demand for lab instruments and software helped Thermo Fisher beat earnings estimates and raise its full-year outlook.
Evotec Selects Navan to Unify Global Travel, Payments, and Expense Management
The global drug discovery company will roll out the platform across five countries, replacing a patchwork of manual, country-specific expense processes.